Ivan Bièche

34.0k total citations · 1 hit paper
497 papers, 20.2k citations indexed

About

Ivan Bièche is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ivan Bièche has authored 497 papers receiving a total of 20.2k indexed citations (citations by other indexed papers that have themselves been cited), including 248 papers in Molecular Biology, 193 papers in Oncology and 136 papers in Cancer Research. Recurrent topics in Ivan Bièche's work include Cancer Genomics and Diagnostics (72 papers), Cancer-related Molecular Pathways (39 papers) and Estrogen and related hormone effects (37 papers). Ivan Bièche is often cited by papers focused on Cancer Genomics and Diagnostics (72 papers), Cancer-related Molecular Pathways (39 papers) and Estrogen and related hormone effects (37 papers). Ivan Bièche collaborates with scholars based in France, United States and United Kingdom. Ivan Bièche's co-authors include Rosette Lidereau, Michel Vidaud, Sophie Vacher, Ingrid Laurendeau, Dominique Vidaud, Sengül Tozlu, Éric Pasmant, Igor Girault, Martine Olivi and M.H. Champème and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Ivan Bièche

477 papers receiving 19.9k citations

Hit Papers

Characterization of a Ger... 2007 2026 2013 2019 2007 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ivan Bièche 11.1k 5.9k 5.7k 2.7k 2.6k 497 20.2k
Garrett M. Brodeur 14.4k 1.3× 5.2k 0.9× 6.6k 1.2× 2.9k 1.1× 1.5k 0.6× 244 24.9k
Michael J. Birrer 13.5k 1.2× 9.5k 1.6× 5.1k 0.9× 2.4k 0.9× 2.5k 1.0× 434 25.4k
Leif W. Ellisen 9.4k 0.8× 4.9k 0.8× 3.9k 0.7× 2.1k 0.8× 1.6k 0.6× 152 15.9k
Alfredo Fusco 17.8k 1.6× 7.9k 1.3× 7.2k 1.3× 3.6k 1.3× 2.0k 0.8× 504 29.0k
Kathleen R. Cho 10.5k 1.0× 6.3k 1.1× 4.8k 0.8× 1.8k 0.7× 1.6k 0.6× 152 18.8k
Andres J. Klein–Szanto 12.0k 1.1× 7.0k 1.2× 4.9k 0.9× 1.6k 0.6× 2.6k 1.0× 383 21.3k
Takashi Tokino 12.8k 1.2× 6.5k 1.1× 3.8k 0.7× 1.7k 0.6× 1.3k 0.5× 227 17.4k
Yusuke Nakamura 15.2k 1.4× 8.0k 1.4× 5.4k 0.9× 3.6k 1.3× 2.4k 0.9× 377 25.6k
Eric W.‐F. Lam 15.3k 1.4× 5.4k 0.9× 4.0k 0.7× 1.7k 0.6× 1.3k 0.5× 298 23.1k
Owen J. Sansom 14.4k 1.3× 8.8k 1.5× 4.9k 0.9× 2.2k 0.8× 1.6k 0.6× 311 23.8k

Countries citing papers authored by Ivan Bièche

Since Specialization
Citations

This map shows the geographic impact of Ivan Bièche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Bièche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Bièche more than expected).

Fields of papers citing papers by Ivan Bièche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Bièche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Bièche. The network helps show where Ivan Bièche may publish in the future.

Co-authorship network of co-authors of Ivan Bièche

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Bièche. A scholar is included among the top collaborators of Ivan Bièche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Bièche. Ivan Bièche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boissan, Mathieu, Ivan Bièche, Florent Dingli, et al.. (2024). CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer. Journal of Biological Chemistry. 300(9). 107601–107601. 3 indexed citations
2.
Dall’Olio, Filippo Gustavo, Damien Vasseur, Maryam Karimi, et al.. (2023). Association of ctDNA tumor fraction with survival in advanced non-small cell lung cancer (NSCLC) treated with maintenance durvalumab in the UNICANCER SAFIR02-Lung/IFCT1301 trial.. Journal of Clinical Oncology. 41(16_suppl). 2516–2516.
3.
Moncoutier, Virginie, Mélanie Pagès, Julien Masliah‐Planchon, et al.. (2023). Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh‐frozen breast/ovarian tumor versus blood. Clinical Genetics. 104(1). 107–113. 2 indexed citations
4.
Jeannot, Emmanuelle, Aurélien Latouche, Claire Bonneau, et al.. (2022). 2022-RA-205-ESGO Circulating HPV DNA in cervical cancer: a marker for early detection of relapse. International Journal of Gynecological Cancer. 32. A404–A404. 1 indexed citations
5.
Garinet, Simon, G. Pignot, Sophie Vacher, et al.. (2018). High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer. Molecular Cancer Research. 17(2). 469–475. 18 indexed citations
6.
Weiswald, Louis‐Bastien, Mohammad R. Hasan, John C.T. Wong, et al.. (2017). Inactivation of the Kinase Domain of CDK10 Prevents Tumor Growth in a Preclinical Model of Colorectal Cancer, and Is Accompanied by Downregulation of Bcl-2. Molecular Cancer Therapeutics. 16(10). 2292–2303. 17 indexed citations
7.
Bièche, Ivan, Didier Meseure, Elisabetta Marangoni, et al.. (2016). Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer. Clinical Cancer Research. 23(8). 2116–2126. 26 indexed citations
8.
Meseure, Didier, Sophie Vacher, Kinan Drak Alsibai, et al.. (2016). Expression of ANRIL –Polycomb Complexes– CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene ( EZH2/CBX7 ) Signature with Independent Prognostic Value. Molecular Cancer Research. 14(7). 623–633. 82 indexed citations
9.
Nunes, Manoel, Patricia Vrignaud, Sophie Vacher, et al.. (2015). Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data. Cancer Research. 75(8). 1560–1566. 56 indexed citations
10.
Estrabaud, Emilie, Martine Lapalus, Philippe Broët, et al.. (2014). Reduction of MicroRNA 122 Expression in IFNL3 CT/TT Carriers and during Progression of Fibrosis in Patients with Chronic Hepatitis C. Journal of Virology. 88(11). 6394–6402. 29 indexed citations
11.
Cottu, Paul, Ivan Bièche, Franck Assayag, et al.. (2014). Acquired Resistance to Endocrine Treatments Is Associated with Tumor-Specific Molecular Changes in Patient-Derived Luminal Breast Cancer Xenografts. Clinical Cancer Research. 20(16). 4314–4325. 42 indexed citations
12.
Romanelli, Angela, Franck Assayag, Sophie Château‐Joubert, et al.. (2012). Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts. Molecular Cancer Therapeutics. 11(12). 2693–2703. 40 indexed citations
13.
Vendrell, Julie A., Aurélie Thollet, Nhan Trung Nguyen, et al.. (2012). ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion. Cancer Research. 72(14). 3593–3606. 95 indexed citations
14.
Hill, Victoria, Christopher J. Ricketts, Ivan Bièche, et al.. (2011). Genome-Wide DNA Methylation Profiling of CpG Islands in Breast Cancer Identifies Novel Genes Associated with Tumorigenicity. Cancer Research. 71(8). 2988–2999. 126 indexed citations
15.
Terrier, Benjamin, Ivan Bièche, Thierry Maisonobe, et al.. (2010). Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome. Blood. 116(22). 4523–4531. 99 indexed citations
16.
Ghoul, Aïda, Maria Serova, Lucile Astorgues‐Xerri, et al.. (2009). Epithelial-to-Mesenchymal Transition and Resistance to Ingenol 3-Angelate, a Novel Protein Kinase C Modulator, in Colon Cancer Cells. Cancer Research. 69(10). 4260–4269. 44 indexed citations
17.
Jackson, Amanda, Akeila Bellahcène, Nadia Rucci, et al.. (2008). A Six-Gene Signature Predicting Breast Cancer Lung Metastasis. Cancer Research. 68(15). 6092–6099. 121 indexed citations
18.
Pasmant, Éric, Ingrid Laurendeau, Delphine Héron, et al.. (2007). Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL , an Antisense Noncoding RNA Whose Expression Coclusters with ARF. Cancer Research. 67(8). 3963–3969. 500 indexed citations breakdown →
19.
Lévy, Pascale, Hugues Ripoche, Ingrid Laurendeau, et al.. (2007). Microarray-Based Identification of Tenascin C and Tenascin XB , Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1. Clinical Cancer Research. 13(2). 398–407. 43 indexed citations
20.
Bièche, Ivan, Florence Lerebours, Sengül Tozlu, et al.. (2004). Molecular Profiling of Inflammatory Breast Cancer. Clinical Cancer Research. 10(20). 6789–6795. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026